Flu vaccination in patients with acute coronary syndromes: Treatment benefit in prespecified subgroups;Vacunación antigripal en pacientes con síndromes coronarios agudos: Beneficio del tratamiento en diferentes subgrupos

Revista Espanola de Cardiologia

Volumn 56, Issue 10, 2003, Pages 949-954

  León de la Fuente, Ricardo ^a   Gurfinkel, Enrique P ^a   Toledo, Diego ^a   Mautner, Branco ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

Author keywords

Immunology; Infection; Myocardial infarction

Indexed keywords

AZITHROMYCIN; INFLUENZA VACCINE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA ANALYSIS; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; SECONDARY PREVENTION; SMOKING; ST SEGMENT ELEVATION; TREATMENT OUTCOME; WINTER;

EID: 0242691090     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13052382     Document Type: Article

References (23)

1. Chierchia SL. Inflamación y síndrome coronario agudo. Rev Esp Cardiol 2001;54:1135-40.
2. Woodhouse PR, Khaw KT, Plummer M, Foley A, Meade TW. Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet 1994;343:435-9.
3. Tillet HE, Smith JWG, Gooch CD. Excess death attributable to influenza in England and Wales: age at death and certified cause. Int J Epidemiol 1983;12:344-52.
4. Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W. Association of Influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000;102:3039-45.
5. Lavallee P, Perchaud V, Gauier-Bertrand M, Grabli D, Amarenco P. Association between Influenza vaccination and reduced risk of brain infarction. Stroke 2002;33:513-8.
6. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group. Lancet 1997; 350:404-7.
7. Cox RJ, Brokstad KA, Zuckerman MA, Wood JM, Haaheim LR, Oxford JS. An early humoral response in peripheral blood following parenteral inactivated Influenza vaccination. Vaccine 1994:12:993-9.
8. Brokstad KA, Cox RJ, Olofsson J, Jonsson R, Haaheim LR. Parenteral Influenza vaccination induces a rapid systemic and local immune response. J Infect Dis 1995;171:198-203.
9. Gurfinkel E, León de la Fuente R, Mendiz O, Mautner B. Influenza vaccine pilot study in acute myocardial infarction and planned percutaneous coronary intervention. The Flu Vaccination Acute Coronary Syndromes (FLUVACS) Study Group. Circulation 2002;105:2143-8.
10. World Health Organization. Communication Disease Surveillance and Response (CRL). Weekly Epidemiological Record. 2000; 75:41 [consultado el 18/03/2002]. Disponible en: www.who.int/disease/flu/index.html
11. Gurfinkel E, Mautner B. Prevención secundaria de la cardiopatía isquémica con la vacuna antigripal. Nueva evidencia sobre el papel de la infección y los síndromes coronarios agudos. Rev Esp Cardiol 2002;55:1009-12.
12. Kaski JC, Cruz-Fernández JM, Fernández-Bergés D, García-Moll X, Martín Jadraque L, Mostaza J, et al. Marcadores de inflamación y estratificación de riesgo en pacientes con síndrome coronario agudo: diseño del estudio SIESTA (Systemic Inflammation Evaluation in patients with non-ST segment elevation Acute coronary syndrome). Rev Esp Cardiol 2003;56:389-95.
13. Cohen M, Demers C, Gurfinkel EP, Turpie AG, Fromell GJ, Goodman S, et al. for the Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. A comparison of low molecular weight heparin With unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997:337:447-52.
14. Antman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, et al. for the TIMI 11B Investigators. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: results of the Thrombolysis In Myocardial Infarction (TIMI) 11B trial. Circulation 1999;100: 1593-601.
15. Cohen M, Antman EM, Gurfinkel E, Radley D. Enoxaparin in unstable angina/non-ST-segment elevation myocardial infarction: treatment benefits in prespecified subgroups. J Thromb Thrombolysis 2001;12:199-206.
16. Gurfinkel E, Bozovich G, Beck E, Testa E, Livellara B, Mautner B. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study. Eur Heart J 1999;20:121-7.
17. Cercek B, Shah PK, Noc M, Zahger D, Zeymer U, Matetzky S, et al, for AZACS Investigators. Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial. Lancet 2003;361:809-13.
18. Ramires JAF, Higuchi ML. Mycoplasma pneumoniae y Chlamydia pneumoniae se asocian con la inflamación y la rotura de las placas coronarias ateroscleróticas. Rev Esp Cardiol 2002;55(Supl 1):2-9.
19. Dimayuga P, Cercek B, Oguchi S, Fredikson GN, Yano J, Shah PK, et al. Inhibitory effect on arterial injury-induced neointimal formation by adoptive b-cell transfer in rag-1 knockout mice. Arterioscler Thromb Vasc Biol 2002;22:644-9.
20. Caliguri G, Nicoletti A, Poirier B, Hansson GK. Protective immunity against atherosclerosis carried by B cell of hypercholesterolemic mice. J Clin Invest 2002;109:721-4.
21. Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, Penninger JM. Chlamydia infections and heart disease linked through antigenic mimicry. Science 1999;283:1238-9.
22. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalization for cardiac disease and stroke among the elderly. N Engl J Med 2003;348: 1322-32.
23. Zahn R, Schneider S, Frilling B, Seidl K, Tebbe U, Weber M. et al. Antibiotic therapy after acute myocardial infarction: a prospective randomized study. Circulation 2003;107:1253-9.